Like copyright, Wegovy incorporates the Lively component semaglutide. The primary difference between the two is always that copyright is now approved for Type 2 diabetes and kidney illness, and Wegovy is currently accepted for pounds management. (The two are accredited for cardiovascular possibility reduction.) This may complicate insurance policie